Added to YB: 2026-01-28
Pitch date: 2026-01-26
TEM [neutral]
Tempus AI, Inc.
-30.32%
current return
Author Info
No bio for this author
Company Info
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$8.4B
Pitch Price
$67.88
Price Target
97.30 (+106%)
Dividend
N/A
EV/EBITDA
-57.12
P/E
-33.40
EV/Sales
7.05
Sector
Life Sciences Tools and Services
Category
growth
TEM | Tempus AI Q3 2025 Financial Highlights
TEM (earnings): Healthcare AI platform w/ 84.7% revenue growth to $334M, driven by M&A (Ambry, Paige). Genomics +117%, data +26%. First positive adj EBITDA $2M. Paige Predict launched for AI-powered pathology diagnosis. High-margin data licensing is key value driver. DCF intrinsic value $54.75 vs current $64.84. Risk: M&A-driven growth may decelerate, integration challenges, regulatory risks. 9.1x PS ratio reasonable given growth but not cheap.
Read full article (9 min)